First Patients Treated in Global Clinical Trial Evaluating Impact of Therapy on Predominant Low Back Pain Medtronic, Inc. (NYSE: MDT) have announced the start of PROMISE, a Prospective, Randomized Study of Multicolumn Implantable Lead Stimulation for Predominant Low Back Pain...

Read more...